Tallac Therapeutics
About:
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Website: https://www.tallactherapeutics.com/
Top Investors: MRL Ventures Fund, Morningside Venture Investments, Horizon Technology Finance, Matrix Partners China, venBio Partners
Description:
Tallac Therapeutics offers next-generation immunotherapies for cancer patients. The company is based in Burlingame, California.
Total Funding Amount:
$88.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Burlingame, California, United States
Founded Date:
2018-01-01
Founders:
Ayman Kabakibi, Corey Goodman, Hong I. Wan, Sukumar Sakamuri
Number of Employees:
11-50
Last Funding Date:
2023-08-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai